These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 11572838

  • 1. By the way, doctor. I'm one year into menopause and really bothered by hot flashes and vaginal dryness. I'd like to take hormone replacement therapy, but I'm worried about increasing my risk of getting breast cancer. My doctor said I can take HRT at a dose longer than what's usually prescribed. What do you think?
    Robb-Nicholson C.
    Harv Womens Health Watch; 2001 Sep; 9(1):7. PubMed ID: 11572838
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. By the way, doctor. I'm 53 and have been taking HRT with Estradiol and Prometrium daily for about a year. Should I also take a soy vitamin supplement? I took one before starting HRT because I thought it was supposed to prevent breast cancer. But I want to be on as little estrogen as possible. Will soy along with estrogen increase my risk of breast tumors?
    Robb-Nicholson C.
    Harv Womens Health Watch; 2000 Feb; 7(6):8. PubMed ID: 10637033
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA, Mengchún López G, Hernández Marín I, Mendoza R, Ayala Ruíz AR.
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [Abstract] [Full Text] [Related]

  • 9. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 10. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
    Alvarez-Vasquez RB, Axelrod D, Frenkel K, Newman MC, Sepkovic DW, Bradlow HL, Zumoff B.
    Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
    [Abstract] [Full Text] [Related]

  • 11. I'm a 57-year-old man with high blood pressure and high cholesterol. I had a hard time regulating my pressure until I went on Vasotec, which was great. But I developed a cough, so my doctor switched me to Cozaar. My cough stopped and my pressure seems okay, but I'd like to know what you think of the switch.
    Harv Mens Health Watch; 1998 May; 2(10):8. PubMed ID: 9577264
    [No Abstract] [Full Text] [Related]

  • 12. Ask the doctor: I just got a new pair of soft contact lenses. They are very comfortable, and my ophthalmologist told me I can keep them in for a week. I'd like to wear them all the time, but I'm not sure it's safe. What do you think?
    Simon HB.
    Harv Mens Health Watch; 2000 Feb; 4(7):8. PubMed ID: 10637027
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. On call. I'm a 63-year-old man with arthritis but no other conditions. My only medicines were Naprosyn and vitamins until my last annual checkup, when my cholesterol was high. My doctor gave me Zocor, which helped. But I developed muscle aches, so he switched me to Zetia. I feel fine again, but I'd like to know what you think.
    Simon HB.
    Harv Mens Health Watch; 2004 Apr; 8(9):8. PubMed ID: 15100066
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of two different dosages of conjugated equine estrogen in continuous combined hormone replacement therapy with progestin.
    Xing S, Wu Y, Liu J, Xu R, Zhang Z, Wang Y.
    Chin Med J (Engl); 2003 Apr; 116(4):584-7. PubMed ID: 12875727
    [Abstract] [Full Text] [Related]

  • 16. Hormone replacement therapy in women with a history of breast cancer.
    Ylikorkala O, Metsä-Heikkilä M.
    Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR.
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [Abstract] [Full Text] [Related]

  • 19. Climacteric symptom control after the addition of low-dose esterified conjugated estrogens to raloxifene standard doses.
    Carranza-Lira S, Gooch AL, Saldivar N, Osterwalder MS.
    Int J Fertil Womens Med; 2007 Nov; 52(2-3):93-6. PubMed ID: 18320867
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.